Full-Time

Data Fabric Architecture & Governance Engineer

Posted on 4/16/2025

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$99.5k - $156.4k/yr

+ Short-term Incentives + Long-term Incentives

Senior

Boston, MA, USA

This position is currently classified as 'hybrid' following Takeda's Hybrid and Remote Work policy.

Category
Data Management
Data Engineering
Data & Analytics
Required Skills
Python
SQL
AWS
Requirements
  • A minimum of a Bachelor’s degree in Pharmaceutical Sciences, Data Science, Computer Science, Information Systems, or a related field is required.
  • At least 5 years (Bachelor’s) or 3 years (Master’s) of substantial experience in data architecture and data governance.
  • Profound knowledge of CMC (Chemistry, Manufacturing and Controls) is preferred, and experience should include implementing and enforcing standards and policies, conducting audits, setting and tracking KPIs, and maintaining high standards of data quality, integrity and compliance.
  • Basic understanding of data management concepts, including data architecture, metadata, and data governance.
  • Familiarity with SQL, Python, or other scripting languages for data manipulation and automation.
  • Exposure to cloud platforms (AWS) and data integration concepts is a plus.
  • Knowledge of current and upcoming regulatory requirements around data integrity, including comprehensive understanding of ALCOA++ principles and other relevant data protection standards like GDPR and HIPAA.
  • Robust communication skills are necessary for explaining complex concepts and policies across all organizational levels and to external stakeholders.
  • Strong analytical and problem-solving skills are essential for identifying and addressing issues, developing effective solutions, and implementing changes that enhance data integrity and operational efficiency.
Responsibilities
  • Support the design and implementation of a data fabric architecture.
  • Support data governance initiatives.
  • Maintain and update data documentation.
  • Contribute to data quality definition and monitoring.
  • Assist in the design and implementation of a data fabric architecture to ensure seamless data integration and management across the organization.
  • Support data governance initiatives by helping to establish and enforce data policies, standards, and best practices.
  • Collaborate with cross-functional teams to understand data requirements and provide solutions that align with business objectives.
  • Participate in data quality assessments and contribute to the development of data quality improvement plans.
  • Help maintain and update data documentation, including data dictionaries, metadata repositories, and data lineage information.
  • Contribute to the development and maintenance of data models and data flow diagrams.
  • Assist in troubleshooting and resolving data-related issues, ensuring data integrity and consistency.
  • Stay current with industry trends and emerging technologies in data architecture and governance.
Desired Qualifications
  • A Master’s degree in Pharmaceutical Sciences, Data Science, Computer Science, Information Systems, or a related field is preferred for its depth of theoretical and practical knowledge.
  • Profound knowledge of CMC (Chemistry, Manufacturing and Controls) is preferred.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.